drugset / Trial / NCT06057103
A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects
Non-randomizedCrossoverOpen-labelTreatment
Summary
The primary object of this study is evaluating the effect of multiple oral oseltamivir phosphate capsules on the pharmacokinetic profile of the active metabolite ZX-7101 after a single oral administration of ZX-7101A tablet in healthy Chinese adult subjects. The seongdary object is evaluating combined or uncombined multiple oral oseltamivir phosphate in healthy Chinese adult subjects.
Timeline
- Start
- 2023-08-28
- Primary completion
- 2023-12-05
- Completion
- 2024-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oseltamivir | Small molecule | 75 mg | Oral |
| Subject | ZX-7101A | Unknown | 80 mg | Oral |
Indications
No indication recorded.